sequence under fasting conditions
Sponsors
Bio-innova and Synchron Co., Ltd., Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence study in healthy Thai volunteers
Bioequivalence,Bioequivalence study in healthy volunteers
Phase 1
Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two treatment and two-sequence of Azithromycin Capsules (250 mg) relative to ZITHROMAX 250 (Original Azithromycin Capsules (250 mg) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20170110001
Start: 2017-01-06Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Deferasirox 250 mg dispersible tablets relative to Exjade® 250 mg dispersible tablets in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20180705002
Start: 2019-01-31Target: 38Updated: 2026-03-30